Safety, pharmacokinetics and efficacy findings in an open-label, single-arm study of weekly paclitaxel plus lapatinib as first-line therapy for Japanese women with HER2-positive metastatic breast cancer
Crossref DOI link: https://doi.org/10.1007/s10147-015-0832-5
Published Online: 2015-05-13
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Inoue, Kenichi
Kuroi, Katsumasa
Shimizu, Satoru
Rai, Yoshiaki
Aogi, Kenjiro
Masuda, Norikazu
Nakayama, Takahiro
Iwata, Hiroji
Nishimura, Yuichiro
Armour, Alison
Sasaki, Yasutsuna
License valid from 2015-05-13